Showing Results for
- Academic Journals (11)
Search Results
- 11
Academic Journals
- 11
- Search Terms:
- 1From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedAuthor(s): I Badagnani [1]; W Chan [2]; R A Castro [1]; C M Brett [3]; C C Huang [4]; D Stryke [4]; M Kawamoto [4]; S J Johns [4]; T E Ferrin [4]; E J Carlson [2]; E G Burchard [1, 5]; K M Giacomini [1] INTRODUCTION...
- 2From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedAuthor(s): L J Sheffield [1, 2] The third annual meeting of the International Society of Pharmacogenomics (ISP) was held on the island of Santorini (Greece) as part of the second Biologie and Prospective Santorini...
- 3From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedAuthor(s): Y Freudenberg-Hua [1]; J Freudenberg [1]; J Winantea [1]; N Kluck [1]; S Cichon [1, 2]; M Brüss [3]; P Propping [1]; M M Nöthen [1, 2] INTRODUCTION Pharmacogenetic research is aimed at relating genetic...
- 4From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedAuthor(s): M Lin [1]; C Aquilante [2]; J A Johnson [2]; R Wu [1] Although pharmacogenetics or pharmacogenomics, the study of inherited variation in patients' responses to drugs, is still in its infancy, tremendous...
- 5From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedAuthor(s): D Herman [1]; I Locatelli [2]; I Grabnar [2]; P Peternel [3]; M Stegnar [3]; A Mrhar [2]; K Breskvar [1]; V Dolzan [1] INTRODUCTION Warfarin is an oral anticoagulant drug and the most common coumarin that...
- 6From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedAuthor(s): L J Sheffield [1, 2] This meeting was held in Los Angeles on November 3 and 4, 2003. The historic Millenium Biltmore Hotel was the venue for presentations on the pharmacogenomics of drugs used commonly in...
- 7From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedSecond annual meeting of the ISP Leslie Sheffield begins this issue with a report (pp 144-145) on the International Society of Pharmcogenomics' (ISP) second annual meeting from 2-3 November 2003 in Los Angeles, CA,...
- 8From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedIn the rat, continuous access to d-amphetamine (d-AMPH) leads to lengthy bouts of self-administration, voluntary abstinence, and relapse to self-administration. Previous studies have revealed that the progression from...
- 9From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedNicotine dependence is the most prevalent form of drug addiction in the US and throughout the world. Epidemiological studies demonstrate that genetics accounts for at least 50% of the liability to nicotine dependence....
- 10From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedCytochrome P4502D6 (CYP2D6) genotyping reliably predicts poor metabolizer phenotype in Caucasians, but is less accurate in African Americans. To evaluate discordance we have observed in phenotype to genotype correlation...
- 11From: The Pharmacogenomics Journal. (Vol. 5, Issue 3) Peer-ReviewedAuthor(s): D Wang; J Z Ma; M D Li Correction to: The Pharmacogenomics Journal (2005) 5, 166-172. doi:10.1038/sj.tpj.6500304 Following publication of the above paper, the authors identified errors in Table 2 and...